Trials / Unknown
UnknownNCT06282679
Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea
Clinical Observation of Intradermal Injections With Botulinum Toxin A in the Treatment of Rosacea Erythema Telangiectasia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Nanjing First Hospital, Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
the goal of this study is to study the clinical efficacy and safety of botox in the treatment of rosacea.
Detailed description
The main objective is to collect patients and then use different injection volumes of botulinum toxin intradermal injection for the treatment of rosacea erythema telangiectasia, and then to evaluate the clinical efficacy and safety of the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum Toxin Type A Injection [Botox] | you are asked to return to the hospital for follow-up at weeks 2, 4, 8, and 12 |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2024-03-01
- Completion
- 2024-06-28
- First posted
- 2024-02-28
- Last updated
- 2024-02-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06282679. Inclusion in this directory is not an endorsement.